1-7 of 7
Authors: Matthias Cassia
Journal Article
#1327 mTOR inhibitors in kidney transplant recipients: long-term efficacy and discontinuation causes
Nephrology Dialysis Transplantation, Volume 39, Issue Supplement_1, May 2024, gfae069-0994-1327, https://doi.org/10.1093/ndt/gfae069.994
Published: 23 May 2024
Journal Article
#3052 mTOR inhibitors in kidney transplant recipients with high immunological risk: practical insights from clinical experience
Nephrology Dialysis Transplantation, Volume 39, Issue Supplement_1, May 2024, gfae069-1004-3052, https://doi.org/10.1093/ndt/gfae069.1004
Published: 23 May 2024
Journal Article
FC 101: The Impact of Vascular Access Types on Survival in Hemodialysis: Time for a Shift in Paradigm? A Prospective Cohort Study
Nephrology Dialysis Transplantation, Volume 37, Issue Supplement_3, May 2022, gfac119.006, https://doi.org/10.1093/ndt/gfac119.006
Published: 03 May 2022
Journal Article
P0346THE EFFECTS OF RITUXIMAB MAINTENANCE THERAPY ON LUPUS NEPHRITIS
Nephrology Dialysis Transplantation, Volume 35, Issue Supplement_3, June 2020, gfaa142.P0346, https://doi.org/10.1093/ndt/gfaa142.P0346
Published: 06 June 2020
Journal Article
SaO020RITUXIMAB AS MAINTENANCE THERAPY FOR SYSTEMIC LUPUS ERYTHEMATOSUS
Nephrology Dialysis Transplantation, Volume 33, Issue suppl_1, May 2018, Page i323, https://doi.org/10.1093/ndt/gfy104.SaO020
Published: 18 May 2018
Journal Article
MP204SLOWLY PROGRESSIVE GLOMERULONEPHRITIS IN PATIENTS WITH ANCA ASSOCIATED VASCULITIS (AAV)
Nephrology Dialysis Transplantation, Volume 32, Issue suppl_3, May 2017, Pages iii502–iii503, https://doi.org/10.1093/ndt/gfx165.MP204
Published: 26 May 2017
Journal Article
TO037CLINICAL PREDICTORS OF RESPONSE TO RITUXIMAB IN ANCA-ASSOCIATED VASCULITIS: A EUROPEAN COHORT
Nephrology Dialysis Transplantation, Volume 31, Issue suppl_1, May 2016, Page i77, https://doi.org/10.1093/ndt/gfw150.01
Published: 24 May 2016
